International Journal of Infectious Diseases | 2021
A short discussion about the SARS-CoV-2 mRNA-1273 vaccine
Abstract
\n The COVID-19 global pandemic has prompted accelerated vaccine development efforts. This perspective discusses the importance of SARS-CoV-2 vaccine candidates’ recruitment of cellular T-cell immunity and encourages industry to increasingly investigate and publish parameters related to cellular immunity in their research reports.\n